NCT01610297View on ClinicalTrials.gov

Post Hematopoietic Stem Cell Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
Interventions
DRUG

ICL670

Oral dose of ICL670 at 10 mg/kg daily

Trial Locations (6)

35040

Novartis Investigative Site, Izmir

06100

Novartis Investigative Site, Ankara

06500

Novartis Investigative Site, Ankara

07000

Novartis Investigative Site, Antalya

07070

Novartis Investigative Site, Antalya

Unknown

Novartis Investigative Site, Istanbul

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY